Basecamp Wealth Advisors’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.77K Sell
13
-51
-80% -$6.27K ﹤0.01% 1398
2026
Q1
$7.54K Hold
64
﹤0.01% 1094
2025
Q4
$10.5K Buy
+64
New +$10K ﹤0.01% 953

Other funds holding RGEN

Basecamp Wealth Advisors's RGEN Position: Q2 2026 in Review

Basecamp Wealth Advisors reduced its Repligen (RGEN) stake by 80% in Q2 2026, selling an estimated $6.27K and leaving 13 shares worth $1.77K. The position accounts for ﹤0.01% of the portfolio, ranked #1398.

Basecamp Wealth Advisors first reported a position in RGEN in Q4 2025 and has held it in 3 quarters since. The position peaked at $10.5K in Q4 2025. 478 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • Basecamp Wealth Advisors held 13 shares of Repligen worth $1.77K as of Q2 2026.
  • Basecamp Wealth Advisors sold 51 Repligen shares in Q2 2026, an estimated $6.27K.
  • Repligen made up ﹤0.01% of Basecamp Wealth Advisors's portfolio in Q2 2026, its #1398 holding.
  • Basecamp Wealth Advisors first reported a position in Repligen in Q4 2025 and has held it in 3 quarters since.
  • Basecamp Wealth Advisors's Repligen position peaked at $10.5K in Q4 2025.
  • 478 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on Basecamp Wealth Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.